Skip to main content

Table 1 Clinical and biochemical characteristics of CABG patients and control subjects

From: Endothelial nitric oxide synthase gene polymorphisms -786T >C and 894G >Tin coronary artery bypass graft surgery patients

 

CABG patients

controls

p

value

Number of subjects (n)

154

155

 

Male/female

122/32

115/40

ns

Mean age (years)

68 ± 8

72 ± 9

<0.01

BMI

28.44 ± 3.72

28.82 ± 4.57

ns

Total cholesterol (mg/dl)

169.97 ± 45.78

233.54 ± 46.18

<0.001

HDL-cholesterol (mg/dl)

47.06 ± 10.49

53.32 ± 10.29

<0.001

LDL-cholesterol (mg/dl)

94.13 ± 37.33

152.51 ± 40.00

<0.001

Triglycerides (mg/dl)

154.96 ± 72.79

132.84 ± 68.65

<0.01

Glucose (mg/dl)

123.59 ± 43.18

113.54 ± 32.21

0.03

MI

68 (44.2)

-

 

Hypertension

106 (68.8)

65 (41.9)

<0.001

Diabetes

63 (40.9)

37 (23.9)

<0.01

Current/past-smokers

72 (46.8)

65 (41.9)

ns

  1. Categorical variables are presented as n (per cent) and were analysed between groups using the chi-square test; all continuous variables are expressed as mean ± standard deviation and were compared using the unpaired Student's t test.
  2. Abbreviations: BMI, body mass index; HDL, high-density lipoprotein; LDL, low-density lipoprotein; MI, myocardial infarction; NS, not significant.